ExxonMobil Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $4.07M | Sell |
11,822
-427
| -3% | -$147K | 0.12% | 200 |
|
|
2017
Q4 | $4.61M | Sell |
12,249
-1,781
| -13% | -$670K | 0.13% | 187 |
|
|
2017
Q3 | $6.27M | Sell |
14,030
-600
| -4% | -$268K | 0.16% | 153 |
|
|
2017
Q2 | $7.19M | Sell |
14,630
-2,257
| -13% | -$1.11M | 0.18% | 136 |
|
|
2017
Q1 | $6.54M | Sell |
16,887
-611
| -3% | -$237K | 0.14% | 170 |
|
|
2016
Q4 | $6.42M | Sell |
17,498
-1,772
| -9% | -$650K | 0.14% | 173 |
|
|
2016
Q3 | $7.75M | Sell |
19,270
-920
| -5% | -$370K | 0.16% | 152 |
|
|
2016
Q2 | $7.05M | Buy |
20,190
+1,180
| +6% | +$412K | 0.15% | 158 |
|
|
2016
Q1 | $6.85M | Buy |
19,010
+1,609
| +9% | +$580K | 0.16% | 153 |
|
|
2015
Q4 | $9.45M | Sell |
17,401
-349
| -2% | -$189K | 0.23% | 103 |
|
|
2015
Q3 | $8.26M | Buy |
17,750
+1,013
| +6% | +$471K | 0.21% | 116 |
|
|
2015
Q2 | $8.54M | Sell |
16,737
-1,004
| -6% | -$512K | 0.21% | 122 |
|
|
2015
Q1 | $8.01M | Buy |
17,741
+244
| +1% | +$110K | 0.18% | 138 |
|
|
2014
Q4 | $7.18M | Sell |
17,497
-582
| -3% | -$239K | 0.17% | 149 |
|
|
2014
Q3 | $6.52M | Sell |
18,079
-2,197
| -11% | -$792K | 0.15% | 162 |
|
|
2014
Q2 | $5.73M | Sell |
20,276
-349
| -2% | -$98.6K | 0.13% | 192 |
|
|
2014
Q1 | $6.19M | Buy |
20,625
+180
| +0.9% | +$54K | 0.14% | 179 |
|
|
2013
Q4 | $5.63M | Sell |
20,445
-295
| -1% | -$81.2K | 0.13% | 190 |
|
|
2013
Q3 | $6.49M | Sell |
20,740
-485
| -2% | -$152K | 0.16% | 148 |
|
|
2013
Q2 | $4.77M | Buy |
+21,225
| New | +$4.77M | 0.12% | 202 |
|